Member access

4-Traders Homepage  >  Shares  >  OTC Bulletin Board  >  IntelGenx Technologies Corp.    IGX   US45822R1014

 SummaryNewsCalendarCompanyFinancials 
Company
IntelGenx Technologies Corp. operates as a drug delivery company. It focuses on the development of novel, orally administered drug delivery products based on its proprietary oral drug delivery technologies. The company is a provider of product development services for the pharmaceutical industry,... 
Sector
Pharmaceuticals
Calendar
09/09 | 09:35amPresentation
More about the company
Financials ($)
Sales 2011 6,00 M
EBIT 2011 -0,10 M
Net income 2011 -0,10 M
Debt 2011 -
Yield 2011 -
Sales 2012 0,97 M
EBIT 2012 -1,88 M
Net income 2012 -2,14 M
Debt 2012 -
Yield 2012 -
PER 2011 27,08
PER 2012
Capi. / Sales 2011 5,70x
Capi. / Sales 2012 35,4x
Capitalization 34,2 M
More Financials
Latest news on INTELGENX TECHNOLOGIES COR
7d ago INTELGENX TECHNOLOGIES : 2014-08-21 IntelGenx to Present at the Rodman & Renshaw..
7d ago IntelGenx to Present at the Rodman & Renshaw Global Investment Conference
08/07 IntelGenx Reports Q2, 2014 Results and Provides Corporate Development Update
08/07 INTELGENX TECHNOLOGIES : 2014-08-07 IntelGenx Reports Q2, 2014 Results and Provi..
07/22 INTELGENX TECHNOLOGIES : 2014-07-18 IntelGenx to Host Management Call
07/18 INTELGENX TECHNOLOGIES : 2014-07-15 IntelGenx to Host Management Call
07/18 IntelGenx to Host Management Call
07/15 IntelGenx Announces Management Changes
07/15 INTELGENX TECHNOLOGIES : 2014-07-15 IntelGenx Announces Management Changes
07/02 INTELGENX TECHNOLOGIES : 2014-07-01 IntelGenx Announces Equity Analyst Coverage ..
07/01 IntelGenx Announces Equity Analyst Coverage by H.C. Wainwright
05/21 INTELGENX TECHNOLOGIES : 2014-05-13 IntelGenx and RedHill Biopharma Report Posit..
More news
Comments 
Advertisement
Income Statement Evolution
IntelGenx Technologies Cor : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF